title: Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: report of 2 cases successfully treated with methotrexate.
authors.forename: B Ben
authors.initials: BB
authors.lastname: Said
authors.forename: J
authors.initials: J
authors.lastname: Kanitakis
authors.forename: I
authors.initials: I
authors.lastname: Graber
authors.forename: J F
authors.initials: JF
authors.lastname: Nicolas
authors.forename: J C
authors.initials: JC
authors.lastname: Saurin
authors.forename: F
authors.initials: F
authors.lastname: Berard
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D017514:Pityriasis Lichenoides / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D008727:Methotrexate